GW Pharmaceuticals PLC
Change company Symbol lookup
Select an option...
GWPH GW Pharmaceuticals PLC
LMT Lockheed Martin Corp
TELL Tellurian Inc
PFE Pfizer Inc
AGNC Agnc Investment Corp
AAPL Apple Inc
GRTYA Guaranty Corp
SATS EchoStar Corp
$DJI Dow Jones Industrials
TIKK Tel-Instrument Electronics Corp
Go

Health Care : Pharmaceuticals | Mid Cap Value
Based in United Kingdom
Company profile

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company is also focused on developing its pharmaceutical product pipelines, which includes Epidiolex for the treatment of Tuberous Sclerosis Complex and RETT Syndrome.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Postmarket

Last Trade
Delayed
$137.69
0.20 (0.15%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$137.49
Day's Change
1.05 (0.77%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
139.44
Day's Low
135.33
Volume
(Light)
Volume:
170,984

10-day average volume:
366,025
170,984

Nio's stock falls 4.8% in premarket trading, after dropping 7.7% on Friday

8:36 am ET November 16, 2020 (MarketWatch)
Print

(END) Dow Jones Newswires

November 16, 2020 08:36 ET (13:36 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.